Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Clinical results of Intraductal Meibomian gland probing combined with intense pulsed light in treating patients with refractory obstructive Meibomian gland dysfunction: a randomized controlled trial

Fig. 2

Comparation of SPEED score, TBUT and CFS after treatment in 3 groups (IPL, MGP, MGP-IPL). Notes: all parameters prior treatment had no statistical differences among 3 groups. *P ≤ 0.05/3, **P<0.001; “AFTER” was determined as 3 weeks after final treatment for groups I and III and 12 weeks after final treatment for group II, the same below

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us